No Data
No Data
Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal 2024 Financial Results
Aurora Spine Announces the Resignation of Board Director James Snow
Aurora Spine Announces Publication of Biomechanical Study Demonstrating Superiority of SiLO TFX Sacroiliac Fusion System
Aurora Spine Announces FDA 510(k) Clearance for the AERO Facet Fusion System
Aurora Spine to Attend the American Academy of Orthopaedic Surgeons Annual Meeting
Aurora Spine Corporation Announces Completion of Enrollment in Groundbreaking REFINE Study: First Prospective, Multi-Center, Multi-Specialty Study on Lumbar Interlaminar Fusion